SELLAS Life Sciences (SLS) EBT (QoQ) (2012 - 2026)
SELLAS Life Sciences (SLS) EBT (QoQ) (2012 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,102.16 Bn | 67,101.87 Bn | - |
| 2 | Nanobiotix | 1,908.96 Bn | 1,908.90 Bn | - |
| 3 | Akari Therapeutics | 959.56 Bn | 959.56 Bn | - |
| 4 | BeOne Medicines | 474.03 Bn | 469.24 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 122.13 Bn | 114.88 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 70.09 Bn | 61.34 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.34 Bn | 62.34 Bn | - |
| 8 | Argenx Se | 55.96 Bn | 50.77 Bn | 1.41 Bn |
| 9 | Alnylam Pharmaceuticals | 37.53 Bn | 34.52 Bn | 959.66 Mn |
| 10 | SELLAS Life Sciences | 1.86 Bn | 1.75 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -80.17% |
| Dec 31, 2025 | -14.72% |
| Sep 30, 2025 | 18.43% |
| Jun 30, 2025 | -42.57% |
| Mar 31, 2025 | 10.76% |
| Dec 31, 2024 | 5.53% |
| Sep 30, 2024 | 3.78% |
| Jun 30, 2024 | 20.77% |
| Mar 31, 2024 | -17.74% |
| Dec 31, 2023 | 12.51% |
| Sep 30, 2023 | -3.40% |
| Jun 30, 2023 | 19.60% |
| Mar 31, 2023 | -17.99% |
| Dec 31, 2022 | -33.12% |
| Sep 30, 2022 | 16.93% |
| Jun 30, 2022 | 48.19% |
| Mar 31, 2022 | -43.66% |
| Dec 31, 2021 | -65.59% |
| Sep 30, 2021 | -55.44% |
| Jun 30, 2021 | -94.16% |